Impact of Model‐Informed Drug Development on Drug Development Cycle Times and Clinical Trial Cost

Documenti analoghi

• Biomarkers of Drug‐Induced Kidney Injury: Use in Clinical Trials and Recent Examples of Impact on Drug Development
  di: Tanja S. Zabka, et al.
  Pubblicazione: (2025)
• Extended Model‐Informed Drug Development: Beyond Clinical Trials and Regulatory Approval
  di: Mohamed A. Kamal, et al.
  Pubblicazione: (2024)
• Reflections on Model‐Informed Drug Development
  di: Lawrence J. Lesko, et al.
  Pubblicazione: (2024)
• New Horizons of Model Informed Drug Development in Rare Diseases Drug Development
  di: Amitava Mitra, et al.
  Pubblicazione: (2024)
• Bridging the Gap: Integrating Quantitative Systems Pharmacology and Pharmacometrics in Drug Development
  di: Georgi I. Kapitanov, et al.
  Pubblicazione: (2025)